newsfilter
← Latest News
PR Newswire·

Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 Million

Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced preliminary unaudited Andexxa global net revenues for the fourth quarter and full year...